MEDTRONIC deep brain stimulation therapy is indicated for the unilateral orbital stimulation of the internal pale globe (IPG) or the sub-thalamic nucleus (STN) in the following cases: depharkinson disease: indicated for adjuvant therapy in the reduction of some of the symptoms of advanced Parkinson's disease in patients with a response to levodopa and who do not control it adequately with medication. Trembling and dikinesias: indicated for the suppression of tremor in the upper extremities. Intended for patients diagnosed with essential tremor or tremor associated with Parkinson's disease not adequately controlled by medication and where the tremor constitutes a significant loss of functionality. Dystonia: indicated as aid for the treatment of intractable chronic primary dystonia (resistant to medication), including generalized and segmental dystonia, hemidystonia and cervical dystonia (torticollis), for people 7 years of age or older. Epilepsy: indicated as therapy adjuvant to reduce the frequency of seizures in adult patients diagnosed with epilepsy characterized by initial partial seizures with or without secondary generalization resistant to antiepileptic drugs. Obsessive-compulsive disorder: indicated for the bilateral stimulation of the internal capsule of the anterior limbus (AIC) as a complement to medication and as an alternative for the treatment of chronic obsessive-compulsive disorder resistant to treatment with serotonin inhibitors.
extensions for deep brain stimulation, model 7483 and 37086, all series.
Description du dispositif
MEDTRONIC deep brain stimulation therapy is indicated for the unilateral orbital stimulation of the internal pale globe (IPG) or the sub-thalamic nucleus (STN) in the following cases: depharkinson disease: indicated for adjuvant therapy in the reduction of some of the symptoms of advanced Parkinson's disease in patients with a response to levodopa and who do not control it adequately with medication. Trembling and dikinesias: indicated for the suppression of tremor in the upper extremities. Intended for patients diagnosed with essential tremor or tremor associated with Parkinson's disease not adequately controlled by medication and where the tremor constitutes a significant loss of functionality. Dystonia: indicated as aid for the treatment of intractable chronic primary dystonia (resistant to medication), including generalized and segmental dystonia, hemidystonia and cervical dystonia (torticollis), for people 7 years of age or older. Epilepsy: indicated as therapy adjuvant to reduce the frequency of seizures in adult patients diagnosed with epilepsy characterized by initial partial seizures with or without secondary generalization resistant to antiepileptic drugs. Obsessive-compulsive disorder: indicated for the bilateral stimulation of the internal capsule of the anterior limbus (AIC) as a complement to medication and as an alternative for the treatment of chronic obsessive-compulsive disorder resistant to treatment with serotonin inhibitors.
MEDTRONIC deep brain stimulation therapy is indicated for the unilateral or bilateral stimulation of the internal pale balloon (IPG) or the sub-thalamic nucleus (STN) in the following cases: Parkinson's disease: indicated for adjuvant therapy in the reduction of some of the symptoms of advanced Parkinson's disease in patients with a response to levodopa and who do not control it adequately with medication. Essential tremor and dikinesias: indicated for the suppression of tremor in the upper extremities. Intended for patients diagnosed with essential contamblor or tremor associated with Parkinson's disease not adequately controlled by medication and where tremor is a significant loss of functionality. Dystonia: indicated as an aid for the treatment of intractable primary chromosome (resistant to medication) dystonia, including generalized and segmental dystonia, hemidystonia, and cervical dystonia (torticollis), for persons 7 years of age or older. Epilepsy: indicated as adjuvant therapy to reduce the frequency of convulsions in adult patients diagnosed with epilepsy characterized by initial partial seizures with or secondary syngeneization resistant to anti-epileptic drugs. Obsessive-compulsive disorder: indicated for bilateral stimulation of the internal capsule of the anterior limbus (AIC) as complement to medication and as an alternative for the treatment of chronic compulsive obsessive-compulsive disorder resistant to treatment with serotonin inhibitors.
MEDTRONIC deep brain stimulation therapy is indicated for the unilateral orbital stimulation of the internal pale globe (IPG) or the sub-thalamic nucleus (STN) in the following cases: Parkinson's disease: indicated for adjuvant therapy in the reduction of some of the symptoms of advanced Parkinson's disease in patients with a response to levodopa and who do not control it adequately with medication. Trembling and dikinesias: indicated for the suppression of tremor in the upper extremities. Intended for patients diagnosed with essential tremor or tremor associated with Parkinson's disease not adequately controlled by medication and where the tremor constitutes a significant loss of functionality. Dystonia: indicated as aid for the treatment of intractable chronic primary dystonia (resistant to medication), including generalized and segmental dystonia, hemidystonia and cervical dystonia (torticollis), for people 7 years of age or older. Epilepsy: indicated as therapy adjuvant to reduce the frequency of seizures in adult patients diagnosed with epilepsy characterized by initial partial seizures with or without secondary generalization resistant to antiepileptic drugs. Obsessive-compulsive disorder: indicated for the bilateral stimulation of the internal capsule of the anterior limbus (AIC) as a complement to medication and as an alternative for the treatment of chronic obsessive-compulsive disorder resistant to treatment with serotonin inhibitors.
Reference Pad - Pak and Pediatric - Pak, lots A1785 up to A1805 and P433 up to P445 respectively, distributed from || May 15, 2014 with new equipment or as a substitute for || consumables
Description du dispositif
It is used to perform electric shocks in cases of cardio-respiratory arrest and fibrillation.
In cardiopulmonary bypass and open heart surgery circuits that require extracorporeal blood circulation as a lung replacement device for the transfer of oxygen and elimination of carbon dioxide as well as for the control of the arteriovenous temperature and as a reservoir of venous blood during these procedures.
Used in the extracorporeal circulation of blood for arterial perfusion, regional perfusion and cardiopulmonary bypass procedures only when used by an expert perpermist in the operation of TERUMOCARDIOVASCULAR SYSTEMS or similar equipment. Centrifugal pump is used in bypass cardiopulmonary procedures only. The pressure monitoring kit is used with physiological pressure transducers that measure the pressure of fluids in an infusion circuit.
ADVIA 560, serial S020202, S020201, S020200 and S020197, with software version 4.1.2133
Description du dispositif
The ADVIA 560 and 360 HEMATOLOGY SYSTEM are a fully automated, high-quality hematology system for use in in vitro diagnostics in clinical laboratories. The system uses the impedance method for the measurement of deleucocyte concentrations (WBC), erythrocytes (RBC) and platelets (PLT). The concentration of hemoglobin (HGB) of the red blood cells semide by photometric refraction. The system provides a differential measurement of the WBC 5-part leukocyte formula (LYM%, MON%, NEU%, EOS%, BAS%) by laser-based optical flow cytometry technology. The ADVIA 560 and the ADVIA 360 HEMATOLOGY SYSTEM identify patients with hematological parameters within and outside the established reference ranges. The system can process up to 100 ul of whole blood that is agicoagulated, automatically for hematology.
The ADVIA 560 AND 360 HEMATOLOGY SYSTEM is a fully automated, high quality hematology system for use in in vitro diagnostics in clinical laboratories. The system uses the impedance method for the measurement of leukocyte (WBC), erythrocyte (RBC) and platelet (PLT) concentrations. The hemoglobin concentration (HGB) of red blood cells is measured by photometric refraction. The system provides a differential measurement of the leukocyte formula of 5 parts of WBC (LYM%, MON%, NEU%, EOS%, BAS%) by laser-based optical flow decitometer technology. The ADVIA 560 and the ADVIA360 HEMATOLOGY SYSTEM identify patients with hematological parameters inside and outside the established reference ranges. The system can process up to 100 μl of blood completely anticoagulated, automatically for hematology.
This equipment is an automated analyzer for blood chemistry tests by colorimetry, enzymatic, endpoint, kinetics, selective ion for continuous random access electrolytes. Uses urine, serum or plasma samples for in vitro diagnostic tests of enzymes, biochemistry, cardiovascular, oncology, anemia, electrolytes, etc. It is an automated system that reports the values of the tests and communicates the clinical results of the patient.
This equipment is an automated analyzer for blood chemistry tests by colorimetry, enzymatic, endpoint, kinetics, selective ion for continuous random access electrolytes. Uses urine, serum or plasma samples for in vitro diagnostic tests of enzymes, biochemistry, cardiovascular, oncology, anemia, electrolytes, etc. It is an automated system that reports the values of the tests and communicates the clinical results of the patient.
This equipment is an automated analyzer for blood chemistry tests by colorimetry, enzymatic, endpoint, kinetics, selective ion for continuous random access electrolytes. Uses urine, serum or plasma samples for in vitro diagnostic tests of enzymes, biochemistry, cardiovascular, oncology, anemia, electrolytes, etc. It is an automated system that reports the values of the tests and communicates the clinical results of the patient.
Reagent used for the determination of analytes of the chemistry area from samples of human origin, this reagent is used with the advia centaur, advia centaur CP, and adviacentaur XP.
Reference. 2789602. code 10317708. || Reference. 2790309. code10317709 || Lots 088, 089, 090, 091, 093, 094
Description du dispositif
Reagents, controls and calibrators used for the determination of analytes of the chemical area from samples of human origin, these reagents are used in ADVIACENTAUR, ADVIA CETAUR CP, ADVIA CENTAUR XP equipment.